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Background. Since vitamin D is a recent known im-
munoregulatory factor in some diseases which are ad-
dressed in immune system disorders such as SLE, [pso-
riasis] and others.
Objective. To determine the serum levels of 25-hydroxy
vitamin D3 [25(OH)D] in patients with acne vulgaris and
its association with clinical features.
Methods. This cross-sectional study was conducted
over months. This study included 39 patients with acne
vulgaris and 40 healthy controls. Subjects who did not
use alcohol, vitamin D supplements, oral steroids or PU-
VA and/or NBUVB for more than three months were in-
cluded. Serum 25(OH)D levels were measured. Baseline
demographics, family history and comorbidities like
PCO were recorded. Statistical analyses were performed
using SPSS 16.0.0.
Results. The median concentration of 25(OH)D was 8.4
ng/mL (range: 1.4-99) in patients and 10.4 ng/mL (range:
3.1-56.7) in controls, with no statistical significant differ-
ence. PCOS was a significant predictor of the occur-
rence of acne vulgaris (OR=6.25; 95% CI: 1.52-25.66;
p=0.01). There were no significant associations between
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Conclusion. Based on the previous studies this is highly
suspected that vitamin D would be a prominent factor in
acne patients and more performances with bigger sam-
ple size could be useful to get positive results.
KEY WORDS: acne vulgaris; serum 25(OH) vitamin D.
Introduction 
Acne vulgaris is a well-known chronic involvement of seba-
ceous follicles which commonly targets individuals’ face,
chest and back. The disease is usually triggered in adoles-
cents among whom sebum production is rising as a result of
androgenic changes in serum sexual hormones. Otherwise,
children would be also affected. Furthermore, this has not
been very rare that some cases with acne vulgaris suffered
from the disease for the rest of their lives (1, 2). An extreme
proliferation of Propionibacter acnes sounds to be the main
predisposing factor in acne vulgaris. This gram positive
anaerobic bacterium settles in skin follicles which are usually
bulged and ruptured due to bacterial proliferation to distrib-
ute local inflammation followed by papules and pustules cre-
ation (3-7). Acne vulgaris is not (indeed) terminated at the
above condition and there are several consequences such
as erythema, post-inflammatory hyperpigmentation (PIH)
and scars. Serious aftermaths would be named as fulminant
acne, acnea conglobuta, septic hydradenitis, acne excoriee
and acne mecanica (1, 2). Each of the mentioned outcomes
could make challenges for patients to draw them to health
providers and physicians as well. Acne vulgaris and relevant
consequences are that much common that nearly all the
adult people experience it at least once during their whole
lives through them 15-20% get [moderate-to-severe] types of
the disease. The disease occurred even as frequent as 85%
in the second decade of life (8, 9). Genders seem to be out
of importance in catching the condition although men show
more severe while women get more permanent types (10).
Many conditions direct the disease to rise such as exposure
to industrial halogenated hydrocarbons, hair styling condi-
tioners, medications like lithium, isoniazid, phenytoin, corti-
costeroids, anabolic steroids, oral contraceptives as well as
iodized antitussives and physical skin effects of sport equip-
ment. There are also some medical conditions which predis-
pose acne vulgaris like polycystic ovaries (PCO) and con-
genital adrenal hyperplasia which need to be evaluated in re-
current referrals. Apart from the named consequences, de-
pression and eating complaints are the most prominent prob-
lems (11-13) which expose patients at the risk of mental and
dietary factors of severe and resistant disease. Concerning
dietary factors, studies have been conducted to show the
role of zinc in treatment of drug-resistant cases of depres-
sion (14, 15). Also these kinds of performances have done
for vitamin D and its effects on acne vulgaris (16-18). Vita-
min D, as an antioxidant agent, would have positive impres-
sion on the disease (19, 20). It seems that vitamin D makes
superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px) which were found at lower levels in papulo-pustu-
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lar cases of acne vulgaris by some Authors (21). Other di-
etary factors like dairy productions have been raised by in-
vestigators in terms of the occurrence of acne vulgaris. Pro-
acneic potentials of milk have been focused as a factor to in-
crease serum level of insulin-like growth factor in the mecha-
nism of the disease onset (22). Otherwise, antimicrobial role
of vitamin D is the other issue to be raised since ancient era
by many authorities and social cultures (23) and focused
now as a treatment hint in acne vulgaris. Not only acne vul-
garis, but also psoriasis, rosacea, vitiligo and similar skin
disorders have been linked to vitamin D and its determinant
impress by several researches (24-33).
This study headed to compare serum levels of 25 (OH) vitamin
D between cases of acne vulgaris and age- and sex-matched
control group to find any relationship between the vitamin and
the occurrence of the disease besides comparing the two
groups in terms of vitamin D deficiency conditions.
The aim of the present study is to compare the serum level
of 25-hydroxy vitamin D in patients with acne vulgaris and
healthy controls and to assess the association between dis-
ease severity and vitamin D deficiency.
Materials and methods
Setting
This cross-sectional study aimed to compare serum concen-
trations of 25(OH)D, as an index for serum vitamin D con-
tent, between patients with acne vulgaris on one hand, and
healthy (individuals) on the other hand. Participants were re-
ferrals to two university hospitals which were well-known
centers of dermatology in shohada-e-tajrish and Rasoul-e-
Akram hospital Tehran, Iran in 2014.
Patients and controls
Patients with acne vulgaris who referred to dermatology de-
partments and clinics at Rasoul-e-Akram and Shohada-e-
Tajrish Hospitals, two referral centers of dermatology in
Tehran were included in the study.
Case group contained all patients over 18 years of age with
acne vulgaris regarding dermatologist physical examination.
A pilot study was done before the main performance to esti-
mate suitable sample size to achieve 80% research study
power and 30 individuals were identified in each group to be
enough. Control group included 30 patients or healthy peo-
ple who did not experience acne vulgaris considering their
medical history and present illness. Participants were ex-
cluded if used alcohol, vitamin D supplements, oral steroids
or PUVA and/or NBUVB in recent three months.
Specimen collection
All the participants gave blood samples after answering a
Data collection form for demographics, past medical history,
family history, and other relevant variables. From all partici-
pants 5 ml peripheral venous blood was drawn to be immedi-
ately centrifuged before freezing at -80°C.
Laboratory study
Vitamin D was detected in the form “25 (OH) vitamin D”
through LIASON chemiluminescent Immunoassay manufac-
tured and provided.
Date Gathering
A data collection form was designed to cover demographics,
patients’ complaints, severity of acne vulgaris by Global Ac-
ne Grading System (GAGS), family history, past medical and
medication history, treatment seeking history for acne and
relevant actions, serum vitamin D profile, daily sun exposure
rate and vitamin D supplement use. Global Acne Grading
System (GAGS) was utilized to score disease severity by the
research dermatologist who visited the patients.
Statistics 
All data analyses were performed using the statistical soft-
ware SPSS 16.0.0. (SPSS Inc. Chicago, IL, U.S.A.). Two-
sided P-values less than 0.05 were considered statistically
significant.
Continuous variables are summarized as mean±SD or as
medians with total and interquartile ranges (25th-75th per-
centiles). Categorical variables were expressed as number
(percentage). The Shapiro-Wilk’s W-test was applied for
checking the normality assumption of continuous variables.
Chi-square test and Fisher’s exact test, wherever appropri-
ate, were used for data analysis. Independent two-sample t-
tests or Mann-Whitney-U tests were applied to compare the
continuous variables between the two groups. Kruskal Wallis
test was used for comparing the median serum 25 (OH) D
levels among the three categories of acne severity. The cor-
relation between acne severity (GAGS score) and other pa-
rameters were assessed with Spearman’s correlation test.
Binary logistic regression models were used to examine the
associations between occurrence of acne vulgaris and other
parameters. 
Ethics 
All the participants including cases and controls gave their
written informed consents after being informed about the
aims and process of the study as well as applicable objec-
tives. The principal investigators have kept individual data as
private information safely. There was no extra fee to be paid
by the participants and the investigators covered all the
costs in this regard.
Results
This study included 39 patients with acne vulgaris (28 fe-
males and 11 males) and 40 healthy controls (28 females
and 12 males). Baseline demographics and clinical charac-
teristics of the participants are presented in Table 1. Patients
with acne were younger than healthy controls (Table 1).
PCO was more frequent in female patients with acne in com-
parison with healthy female individuals with statistical signifi-
cant difference between the two groups (Table 1). Eleven
patients with acne (28.2%) and four healthy subjects (10%)
were exposed to sunlight longer than two hours per day in
average (Table 1). In this study, the two groups did not differ
significantly in gender, BMI, positive family history of acne
and presence of hirsutism (Table 1). 
Serum levels of 25 (OH) D
The two groups did not differ significantly in median serum
concentrations of 25 (OH) D (P value=0.14, Table 2). Thirty-
five patients with acne (89.7%) and 36 healthy subjects
(90%) had hypovitaminosis D (<30 ng/mL), with no signifi-
cant difference between the two groups (P value=0.97, Table
2). According to the subgroup analysis stratified by sun-ex-
posure time, no significant differences were observed in
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serum 25 (OH) D of the two groups in both conditions (Table
2). Furthermore, there were no significant differences in me-
dian serum concentrations of 25 (OH) D among patients with
mild, moderate and severe/very severe acne (P value=0.29,
Table 2). 
Factors associated with acne vulgaris
According to the results of binary logistic regression analysis,
PCO was a significant predictor of the occurrence of acne vul-
garis (OR=6.25; 95% CI: 1.52-25.66; P=0.01). The occurrence
of acne vulgaris was not significantly associated with severe vi-
tamin D deficiency (<10 ng/mL) (OR=1.6; 95% CI: 0.65-3.91;
p=0.30), BMI (OR=0.93; 95% CI: 0.83-1.05; p=0.27), hirsutism
(OR=2.17; 95% CI: 0.72-6.55; p=0.17) and positive family his-
tory of acne (OR=1.08; 95% CI: 0.42-2.73; p=0.88).   
Correlation between disease Severity (GAGS) and evalu-
ated parameters
The mean GAGS score was significantly higher in female pa-
tients with PCO compared to the patients without PCO
(28.58±8.21 vs 21.06±8.79, p=0.03, respectively). However,
there were no significant associations between severity of





=-0.28, p=0.09), BMI (r
s
=-0.12, p=0.46), age at onset of
disease (r
s
=-0.08, p=0.63) and duration of disease (r
s
=-0.10,
p=0.54). Furthermore, no significant difference was found in
mean GAGS score of patients who had exposed to sunlight
less than two hours per day and patients with sun-exposure
time longer than two hours per day (23.82±9.77 vs
27.73±12.39, p=0.36, respectively). The mean GAGS score
did not differ significantly between the female patients with
Clinical Cases in Mineral and Bone Metabolism 2015; 12(3): 238-242240
P. Toossi et al.
"
"
Table 1 - Baseline demographics and clinical characteristics of patients with  and healthy controls. 





Gender   0.86 
   Female 28 (71.8%) 28 (70.0%)  
   Male 11 (28.2%) 12 (30.0%)  
Age, years   0.04 
   MeanSD  24.23±6.45 27.18±5.87  
   Median (range) 23 (12-42) 28 (16-42)  
BMI   0.27 
   MeanSD 22.58±3.57 23.56±4.07  
Sun-exposure time > 2 hours per day 11 (28.2%) 4 (10.0%) 0.04 
Positive family history of acne 26 (66.7%) 26 (65.0%) 0.88 
Hirsutism#   13 (46.4%) 8 (28.6%) 0.17 
PCOS# 12 (42.9%) 3 (10.7%) 0.01 
Age at onset of disease, years    
Median (range); IQR 17 (10-29); (15-19) -  
Duration of disease, years    
   Median (range); IQR 5 (1-25); (2-10) -  
Site of acne  -  
   Face 19 (48.7%)   
   Trunk -   
Both 20 (51.3%)   
Active acne 39 (100%) -  
 
GAGS  -  
MeanSD 24.92±10.57 -  
GAGS categories*  -  
     Mild 12 (30.8%)   
     Moderate  17 (43.6%)   
     Severe 5 (12.8%)   
     Very severe 5 (12.8%)   
Values are no. (%) unless otherwise noted. 
Abbreviations: BMI, Body Mass Index (calculated as weight in kilograms divided by height in meters squared); IQR, Interquartile range 
(25th -75th percentiles); PCOS, Polycystic ovary syndrome; GAGS: Global Acne Grading System. 
# the proportions were calculated in the group of  females; *  A GAGS score of 1-18 is considered mild; 19-30, moderate; 31-38, severe; 
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and without hirsutism (22.23±9.67 vs 26.07±8.71, p=0.28, re-
spectively) and between patients with and without family his-
tory of acne (24.96±10.59 vs 24.85±10.92, p=0.97, respec-
tively).
Discussion
The current study was the first, to our knowledge, in the
evaluation of serum concentration of “25(OH) vitamin D” in
patients with acne vulgaris which compared cases and con-
trols in this regard. There was no significant association be-
tween the occurrence of acne vulgaris and serum 25(OH) vit-
amin D level. Likely, no difference was found between the
disease and sunlight exposure among the patients, although
the event occurred as high as three times more when com-
pared with controls. The mechanism of vitamin D functions in
some medical conditions has been focused by several re-
searches. Youssef et al. as well as other investigators ex-
plained an antibiotic effect for vitamin D and its derivatives
which help infection prevention too (23, 34). This could show
extended impression on a wide microbial spectrum via
strengthening innate and acquired immunity in serum and
skin. Vitamin D is also known by some authorities as a pre-
ventive factor against cancers (35, 36) and skin inflammatory
diseases like psoriasis, ictiosis, etc. in addition to mediating
the beneficial dermatologic effects of light (37).
Not only infections, cancers, acne and inflammatory condi-
tions, but also some regular problems like rosacea would be
under controlled by vitamin D and its derivatives. Ekiz et al.
in 2014 indicated higher rate of vitamin D serum level among
rosacea patients comparing with healthy subjects (38).
In terms of therapeutic potentials of vitamin D and its prod-
ucts, comedolytic effects of the vitamin was introduced by
Ekiz in 2014 (18). Propionibacter acnes is known as the
main microorganism in acne vulgaris and studies have
shown that the bacterium stimulated genes which were
linked to expression of some immunologic factors and cy-
tokines, especially in human T lymphocytes in order to block
vitamin A and vitamin D. This is the main provider of suitable
environment for more microbial proliferation on the skin level
in acne vulgaris (39, 40).
The current work failed to find correlations between history
of PCO and hirsutism and also family history of acne vulgaris
on one hand and the disease, on the other. Unlikely, current
PCO involvement was significantly more frequent among pa-
tients. Coincidence of PCO and acne vulgaris is not a new
issue in this matter. Orio et al. found PCO syndrome and
nonfunctional adenoma in addition to severe hirsutism in a
young woman with acne (41). This would be a hint to ad-
dress complementary endocrine studies on individuals with
hirsutism, virilism and unusual early onset of acne vulgaris,
especially in their twenties.
Among the evaluated parameters through the current study,
PCO was the only parameter which had a significant associ-
ation with acne vulgaris. Serum “25(OH) vitamin D” was not
significantly associated with the occurrence of acne vulgaris.
This would be partially explained by recall bias which re-
minds the fact that people usually forget previous involve-
ment in such a disease as a common complaint. Further-
more, low serum vitamin D contents among Iranians would
be a general problem which rationally bothers the above cor-
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25 (OH) D, ng/mL 8.4 (1.4-99); (5-14.1) 10.4 (3.1-56.7); (6.58-20.25) 0.14 
25 (OH) D categories#, no. (%)    
Severe vitamin D deficiency 24 (61.5%) 20 (50.0%)  
Moderate vitamin D deficiency 9 (23.1%) 10 (25%)  
Vitamin D insufficiency 2 (5.1%) 6 (15%)  
Vitamin D sufficiency 4 (10.3%) 4 (10%)  
 Sun-exposure time     
        < 2 hours per day 8.25 (1.4-99); (4.05-14.62) 10.4 (3.1-56.7); (6.58-20.08)  
        ! 2 hours per day 8.5 (3.3-22.2); (7.7-14.1) 13.5 (5.5-21); (6-20.62)  
 GAGS*  -  
        Mild (n=12) 8.45 (1.7-34.6); (3.08-16.35)   
        Moderate (n=17) 8.6 (1.4-99); (7.2-21.3)   
        Severe/very severe(n=10) 7.05 (3.3-12.8); (3.7-10.3)   
Values are median (range); IQR of serum 25-hydroxyvitamin D, unless otherwise stated.    
Abbreviations: IQR, Interquartile range (25th -75th percentiles); GAGS: Global Acne Grading System 
# Subjects were divided into four categories: Severe vitamin D deficiency [25(OH)D <10 ng/ml], moderate vitamin D deficiency [25(OH)D 
10 to <20 ng/ml], vitamin D insufficiency [25(OH)D 20 to <30 ng/ml] and vitamin D sufficiency [25(OH)D!30 ng/ml] 
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relation because cases and controls in the mentioned popu-
lation face hypovitaminose D. This factor limited us to con-
clude that vitamin D was lower in cases when compared with
controls.
Comprehensive studies with more participants can probably
make vitamin D differences more obvious between the two
groups and finally get a correlation in this regard. 
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